alexa The New Approach In Immunotherapy For Children
ISSN: 2155-6121

Journal of Allergy & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

11th International Conference on ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY
September 07-08, 2017 | Edinburgh, Scotland

Giovanni Maria Traina
University of Milan, Italy
ScientificTracks Abstracts: J Allergy Ther
DOI: 10.4172/2155-6121-C1-005
Abstract
Background: Pediatric sublingual immunotherapy (SLIT) has made it possible to attract many children allergic to desensitization path to inhalants. SLIT determines many compliance problems and sometimes it is difficult to fulfill. The alternative of SLIT is subcutaneous immunotherapy (SCIT), which is commonly performed subcutaneously with needle. This technique has not undergone special changes over the years and it is not without risk or inconvenience. This led to the search for alternative means of administering the vaccine, in order to reduce the discomfort for the child, expanding compliance and increase safety for medical vaccinators and especially reducing the potential risk of adverse reaction. Aim: Aim of this study is to evaluate new route of administration subcutaneous immunotherapy hyposensitizing with device without needle, pain perceived by the patient registration with respect to that traditionally administered by needle, of any adverse events in the course of that procedure and also evaluate difficulties perceived by vaccinating with such methodical. Materials & Methods: Our team together with that of Allergology Hospital Bambino Gesù in Rome has completed a first study, aimed precisely to assess the pain perceived by the patient and safety for the patient and for the operator, with interesting results. For this purpose, 36 patients were recruited and evaluated with oculorhinitis and/or bronchial asthma grass, aged between 5 and 18 years, which were administered under the skin of the arms, polymerized with glutaraldehyde extracted by grasses, with device without needle and with traditional SCIT with needle. They were recorded with dedicated VAS scale, the perceived pain, any adverse reactions and difficulty of the procedure by the vaccinator. Results: All patients completed the study which provided 432 doses of AIT SCIT grasses, of which 216 with device without the needle. The perceived pain was significantly lower than that of immunotherapy administered by needle. In none of them, are adverse events of any grade occurred. It has highlighted the need for adequate training of the performer to better use the device without the needle. Changes made to the device have however solved these problems completely. Conclusions: Vaccination with needleless device has several advantages and guarantees, compared to conventional administration SCIT, best welcome especially by children. This is important, to be able to start early immunotherapy, as recommended by the most recent studies, in order to prematurely change the natural evolution of allergic inflammation. The new technique provides a much higher safety for both the vaccinator that for the vaccinated, with a better acceptance by the patient of the procedure and thus a better and wider adherence to immunization programs. Just for the inoculation technique, such practice may allow a better distribution of the subcutaneous vaccine, with a broader recruitment of Langerhans cells by the antigen and thus a better immunological response.
Biography

Giovanni Maria Traina completed his Graduation in medicine and surgery at university of Messina. He is Specialist in Pediatrics and Allergology Pediatrics at University of Milan, Perugia and Pavia. He is an author of over 25 scientific publications, speaker at over 50 national and international conferences.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords